Pfizer Inc (PFE) Com Stk USD0.05 (CDI)

Sell:$22.19Buy:$22.20$0.10 (0.45%)

Prices delayed by at least 15 minutes
Sell:$22.19
Buy:$22.20
Change:$0.10 (0.45%)
Deal now
Prices delayed by at least 15 minutes
Sell:$22.19
Buy:$22.20
Change:$0.10 (0.45%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.

Key people

Albert Bourla
Chairman of the Board, Chief Executive Officer
David M. Denton
Executive Vice President, Chief Financial Officer
Payal Sahni
Executive Vice President, Chief People Experience Officer
Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
Alexandre De Germay
Executive Vice President, Chief International Commercial Officer
Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Aamir Malik
Executive Vice President, Chief US Commercial Officer
Michael Mcdermott
Executive Vice President, Chief Global Supply Officer
Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Chris Boshoff
Chief Scientific Officer, President - Research & Development
Shantanu Narayen
Lead Independent Director
Ronald E. Blaylock
Independent Director
Mortimer J. Buckley
Independent Director
Susan Desmond-Hellmann
Independent Director
Joseph J. Echevarria
Independent Director
Click to see more

Key facts

  • EPIC
    PFE
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US7170811035
  • Market cap
    $125.00bn
  • Employees
    81,000
  • Shares in issue
    9.60bn
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.